Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Annual Information Update

30 Apr 2010 11:09

RNS Number : 1307L
Maven Income and Growth VCT 3 PLC
30 April 2010
 



MAVEN INCOME AND GROWTH VCT 3 PLC

 

ANNUAL INFORMATION UPDATE

 

Pursuant to the requirements of Prospectus Rule 5.2, the following summarises the information that has been published by the Company throughout the twelve months ending 30 April 2010.

 

Announcements listed as published on the London Stock Exchange have been published via a Regulatory Information Service and can be found on http://londonstockexchange.com/. (The relevant code for the Company is AGW.)

 

Copies of documents at Companies House, including Report and Accounts, can be obtained from Companies House or through Companies House Direct at http:/www.direct.companieshouse.gov.uk. Further details may also be obtained from the Company via its manager at hhtp://www.aberdeen-asset.com.

 

Report and Accounts can also be inspected at the UK Listing Authority's Document Viewing Facility at:

 

Financial Services Authority

25 The North Colonnade

Canary Wharf

London

E14 5HS

 

Tel. 020 7676 1000

 

Some of the information referred to below was provided as at a specific date and may now be out of date.

 

Date

Description

Place of Filing or Publication

23 April 2010

Annual report and Accounts

Companies House

6 April 2010

Issue of Equity

London Stock Exchange

1 April 2010

Issue of Equity

London Stock Exchange

17/3/10

Annual Report and Accounts

UKLA Document Viewing Facility

8/3/10

Annual Financial Report

London Stock Exchange

26/1/10

Linked Offer for Subscription

London Stock Exchange

5/1/10

Total Voting rights

London Stock Exchange

14/12/09

Change of name confirmation

London Stock Exchange

4/12/09

Transaction in own shares

London Stock Exchange

2/11/09

Broker appointment

London Stock Exchange

22/10/09

Interim Management Statement

London Stock Exchange

31/8/09

Total Voting Rights

London Stock Exchange

3/8/09

Transaction in own shares

London Stock Exchange

27/7/09

Half yearly report/dividend record date

London Stock Exchange

24/7/09

Interim announcement

London Stock Exchange

10/6/09

Investment Manager

London Stock Exchange

9/4/09

Result of AGM

London Stock Exchange

9/4/09

Interim Management Statement

London Stock Exchange

6/4/09

Broker appointment

London Stock Exchange

 

 

 

For further information contact:

 

Rosemary O'Neil

Company Secretary, Maven Capital Partners UK LLP

Telephone: 0141 306 7553

Email: rosemary.oneil@mavencp.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIULLFIISDIIVII
Date   Source Headline
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.